Understanding randomized controlled trial generalizability through an embedded molecular diagnostics trial.

Saved in:
Bibliographic Details
Title: Understanding randomized controlled trial generalizability through an embedded molecular diagnostics trial.
Authors: Lewicki P; Department of Urology, University of Michigan, Ann Arbor, MI, United States., Srivastava A; Department of Urology, University of Michigan, Ann Arbor, MI, United States., Jiang R; Department of Biostatistics, University of Michigan, Ann Arbor, MI, United States., Johnson A; Department of Urology, University of Michigan, Ann Arbor, MI, United States., Ghani K; Department of Urology, University of Michigan, Ann Arbor, MI, United States., Ginsburg K; Department of Urology, Wayne State University, Detroit, MI, United States., Borza T; Department of Urology, University of Michigan, Ann Arbor, MI, United States., Stensland K; Department of Urology, University of Michigan, Ann Arbor, MI, United States., Salami SS; Department of Urology, University of Michigan, Ann Arbor, MI, United States., Davicioni E; Veracyte, Inc, South San Francisco, CA, United States., Dunn RL; Department of Urology, University of Michigan, Ann Arbor, MI, United States., Daignault-Newton S; Department of Urology, University of Michigan, Ann Arbor, MI, United States., Palapattu GS; Department of Urology, University of Michigan, Ann Arbor, MI, United States., Spratt DE; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Cleveland, OH, United States., Cher M; Department of Urology, Wayne State University, Detroit, MI, United States., Schipper M; Department of Biostatistics, University of Michigan, Ann Arbor, MI, United States.; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, United States., Dess RT; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, United States., Morgan TM; Department of Urology, University of Michigan, Ann Arbor, MI, United States., Singhal U; Department of Urology, University of Michigan, Ann Arbor, MI, United States.
Source: JNCI cancer spectrum [JNCI Cancer Spectr] 2026 May 09; Vol. 10 (3).
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101721827 Publication Model: Print Cited Medium: Internet ISSN: 2515-5091 (Electronic) Linking ISSN: 25155091 NLM ISO Abbreviation: JNCI Cancer Spectr Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2515-5091
DOI:10.1093/jncics/pkag040